Skip to main content
Clinical Trials/NCT05163457
NCT05163457
Completed
N/A

Prevalence of Frailty Among People Aged 75 and Over Living at Home

Université de Reims Champagne-Ardenne1 site in 1 country100 target enrollmentJanuary 6, 2022
ConditionsFrailty

Overview

Phase
N/A
Intervention
Not specified
Conditions
Frailty
Sponsor
Université de Reims Champagne-Ardenne
Enrollment
100
Locations
1
Primary Endpoint
Frailty
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The aging of population lead to study ways to prevent dependence. Frailty is a precursor to dependence which can be reversible. In the literature, estimate of prevalence of frailty is highly variable depending on the frailty definition, the population studied and the screan tool used. In fact, many scales to measure frailty have emerged without gold standard.

The SEGAm showed its usefulness in aged patients living at home.

Detailed Description

The aim of the study is to describe prevalence of frailty in patients aged of 75 and more living at home.

Registry
clinicaltrials.gov
Start Date
January 6, 2022
End Date
February 22, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Université de Reims Champagne-Ardenne
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • male or female
  • aged of 75 and more
  • living at home
  • agreeing to participate in the study

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Frailty

Time Frame: Day 0

Frailty evaluated using SEGA modified scale (SEGAm). SEGAm includes 13 items (coded from 0 to 2) to obtain a global score out of 26 points. Patients with a score less than or equal to 8 are considered not fragile. Patients with a score between 8 and 11 are considered fragile. Patients with a score greater than or equal to 11 are considered very fragile.

Study Sites (1)

Loading locations...

Similar Trials